Preview

Сибирский онкологический журнал

Расширенный поиск

ПОЧЕМУ НУЖНО ВЫПОЛНЯТЬ РАСШИРЕНЫЕ ОПЕРАЦИ ПРИ РАКЕ ШЕЙКИ МАТКИ?

Полный текст:

Аннотация

В 1993 г. была разработана хирургическая техника расширенной экстирпации матки с тотальным удалением клетчатки и соединительнотканных структур малого таза. Целью разработки данной методики было улучшение онкологических результатов хирургического лечения рака шейки матки за счет снижения риска прогрессирования в малом тазу. Полученные нами результаты демонстрируют, что почти у 90 % операбельных больных раком шейки матки IB стадии выживаемость при применении данной хирургической техники без адъювантного лечения равна или выше таковой при выполнении менее радикальных вмешательств, по показаниям дополненных адъювантной терапией.

Об авторах

Л. Унгар
Отделение акушерства, гинекологии и онкогинекологии, Больница Св. Стефана, Будапешт, Венгрия
Венгрия


В. М. Нечушкина
ФГБУ «РОНЦ им. Н. Н. Блохина» РАМН, г. Москва
Россия


Список литературы

1. ACOG Practice Bulletin, Clinical management guidelines for obstetrician-gynecologists. No35, May 2002: Diagnosis and treatment of cervical carcinomas // Obstet. Gynecol. 2002. Vol. 99. P. 855–866.

2. Averette H.E., Nguyen H.N., Donato D.M. et al. Radical hysterectomy for invasive cervical cancer: a 25-year experience with the Miami technique // Cancer. 1993. Vol. 71. P. 1422–1437.

3. Benedetti-Panici P., Maneschi F., D’Andrea G. et al. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study // Cancer. 2000. Vol. 88. P. 2267–2274.

4. Burghardt E., Pickel H., Haas J. et al. Prognostic factors and operative treatment of stages IB to IIB cervical cancer // Am. J. Obstet. Gynecol. 1987. Vol. 156. P. 988– 996.

5. Chernofsky M.R., Felix J.C., Muderspach L.I. et al. Influence of quantity of lymph node vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix // Gynecol. Oncol. 2006. Vol. 100. P. 288–293.

6. Chung C.K., Nahhas W.A., Stryker J.A. et al. Analysis of factors contributing to treatment failure in stage IB and IIA carcinoma of the cervix // Am. J. Obstet. Gynecol. 1980. Vol. 138. P. 550–556.

7. Cibula D., Abu-Rustum N.R. Pelvic lymphadenectomy in cervical cancer-surgical anatomy and proposal for a new classification system // Gynecol. Oncol. 2010. Vol. 116. P. 33–37.

8. Cibula D., Velechovska P., Sláma J. et al. Late morbidity following nerve-sparing radical hysterectomy // Gynecol. Oncol. 2010. Vol. 116. P. 506–511.

9. Courtney M. Surgery versus chemoradiation as first line therapy for stage IB2 cervical cancer. Abstracts of the 41st Annual Meeting on Women’s Cancer of the Society of Gynecologic Oncologists. March 10–17, 2010. San Francisco, California, USA // Gynecol. Oncol. 2010. Vol. 116 (Suppl. 3). P. S2–S169.

10. Covens A., Rosen B., Murphy J. et al. How important is removal of the parametrium at surgery for carcinoma of the cervix? // Gynecol. Oncol. 2002. Vol. 84. P. 145–149.

11. Creasman W.T., Kohler M.F. Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? // Gynecol. Oncol. 2004. Vol. 92. P. 525–529.

12. Delgado G., Bundy B., Zaino R. et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study // Gynecol. Oncol. 1990. Vol. 38. P. 352–357.

13. DiSaia P.J. Surgical aspects of cervical carcinoma // Cancer. 1981. Vol. 48. P. 548–559.

14. Ferlay J., Shin H.R., Bray F. et al. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2010. [Электронный ресурс]. – URL: http://globocan.iarc.fr (дата обращения: 22.04.12).

15. Frankman E.A., Wang L., Bunker C.H. et al. Lower urinary tract injury in women in the United States, 1979–2006 // Am. J. Obstet. Gynecol. 2010. Vol. 202. P. 495.

16. Fyles A.W., Pintilie M., Kirkbride P. et al. Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis // Radiother. Oncol. 1995. Vol. 35. P. 107–117.

17. Girardi F., Lichtenegger W., Tamussino K. et al. The importance of parametrial lymph nodes in the treatment of cervical cancer // Gynecol. Oncol. 1989. Vol. 34. P. 206–211.

18. Güth U., Ella W.A., Olaitan A. et al. Total vaginal necrosis: a representative example of underreporting severe late toxic reaction after concomitant chemoradiation for cervical cancer // Int. J. Gynecol. Cancer. 2010. Vol. 20. P. 54–60.

19. Hazewinkel M.H., Sprangers M.A., van der Velden J. et al. Long-term cervical cancer survivors suffer from pelvic floor symptoms: a cross-sectional matched cohort study // Gynecol. Oncol. 2010. Vol. 117. P. 281–286.

20. Höckel M., Fritsch H. Dissection bias in subperitoneal pelvic anatomy // Am. J. Obstet. Gynecol. 2006. Vol. 194. P. 1504.

21. Höckel M., Horn L.C., Manthey N. et al. Resection of the embryologically defined uterovaginal (Müllerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis // Lancet Oncol. 2009. Vol. 10. P. 683–692.

22. Horn L.C., Hentschel B., Bilek K. et al. Mixed small cell carcinomas of the uterine cervix: prognostic impact of focal neuroendocrine differentiation but not of Ki-67 abeling index // Ann. Diagn. Pathol. 2006. Vol. 10. P. 140–143.

23. Juretzka M.M., Jensen K.C., Longacre T.A. et al. Detection of pelvic lymph node micrometastases in stage IA2-IB2 cervical can13 cer by immunohistochemical analysis // Gynecol. Oncol. 2004. Vol. 93. P. 107–111.

24. Kashima K., Yahata T., Fujita K. et al. Analysis of the complications after radical hysterectomy for stage IB, IIA and IIB uterine cervical cancer patients // J. Obstet. Gynaecol. Res. 2010. Vol. 36. P. 555–559.

25. Koh W.J., Panwala K., Greer B. Adjuvant therapy for highrisk, early stage cervical cancer // Semin. Radiat. Oncol. 2000. Vol. 10. P. 51–60.

26. Landoni F., Maneo A., Colombo A. et al. Randomised study of radical surgery versus radiotherapy for stage I/b-II/a cervical cancer // Lancet. 1997. Vol. 350. P. 535–540.

27. Landoni F., Maneo A., Cormio G. et al. Class II versus Class III Radical Hysterectomy in Stage IB-IIA Cervical Cancer: A Prospective Randomized Study // Gynecol. Oncol. 2001. Vol. 80. P. 3–12.

28. Landoni F., Maneo A., Zapardiel I. et al. Class I versus class III radical hysterectomy in stage IB1-IIA cervical cancer. A prospective randomized study // EJSO. 2012. Vol. 38. P. 203–209.

29. Lotocki R.J., Krepart G.V., Paraskevas M. et al. Glassy cell carcinoma of the cervix: a bimodal treatment strategy // Gynecol. Oncol. 1992. Vol. 44. P. 254–259.

30. Magara M., Hirishi I., Senda T. Abdominal Radical Operation for Cancer of the Cervix. Tokyo: Nippon Medical School, 1996.

31. Marchiolé P., Buénerd A., Benchaib M. et al. Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study // Gynecol. Oncol. 2005. Vol. 97. P. 727–732.

32. Meigs J.V. Radical hysterectomy with bilateral pelvic lymph node dissection: a report of 100 patients operated on five or more years ago // Am. J. Obstet. Gynecol. 1951. Vol. 62. P. 854–870.

33. Palfalvi L., Ungar L. Laterally extended parametrectomy (LEP), the technique for radical pelvic side wall dissection: Feasibility, technique and results // Int. J. Gynecol. Cancer. 2003. Vol. 13. P. 914–917.

34. Peters W.A., Liu P.Y, Barrett R.J. et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix // J. Clin. Oncol. 2000. Vol. 18. P. 1606–1613.

35. Piver M.S., Rutledge F., Smith J.P. Five classes of extended hysterectomy for women with cervical cancer // Obstet. Gynecol. 1993. Vol. 44. P. 265–272.

36. Quinn M.A., Benedet J.L., Odicino F. et al. 26th annual report on the results of treatment in gynecological cancer // Int. J. Gynecol. Obstet. 2006. Vol. 95. P. S43–S103.

37. Pettersson F., Fotiou S., Einhorn N. et al. Cohort study of the long-term effect of irradiation for carcinoma of the uterine cervix. Second primary malignancies in the pelvic organs in women irradiated for cervical carcinoma at Radiumhemmet 1914–1965 // Acta Radiol. Oncol. 1985. Vol. 24. P. 145–151.

38. Pettersson F., Ryberg M., Malker B. Second primary cancer after treatment of invasive carcinoma of the uterine cervix, compared with those arising after treatment for in situ carcinomas. An effect of irradiation? A cancer registry study // Acta. bstet. Gynecol. Scand. 1990. Vol. 69. P. 161–174.

39. Ralph G., Winter R., Michelitsch L. et al. Radicality of parametrial resection and dysfunction of the lower urinary tract after radical hysterectomy // Eur. J. Gynaecol. Oncol. 1991. Vol. 12. P. 27–30.

40. Rose P.G., Bundy B.N., Watkins E.B. et al. Concurrent cisplatinbased radiotherapy and chemotherapy for locally advanced cervical cancer // N. Engl. J. Med. 1999. Vol. 340. P. 1144–1153.

41. Rutledge T.L., Kamelle S.A., Tillmanns T.D. et al. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference? // Gynecol. Oncol. 2004. Vol. 95. P. 70–76.

42. Sedlis A., Bundy B. N., Rotman M.Z. et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study // Gynecol. Oncol. 1999. Vol. 73. P. 177–183.

43. Stehman F.B., Bundy B.N., DiSaia P.J. et al. Carcinoma of the cervix treated with irradiation therapy. I. A multivariate analysis of prognostic variables in the Gynecologic Oncology Group // Cancer. 1991. Vol. 67. P. 2776–2785.

44. Tarnai L., Ungár L., Pálfalvi L. et al. Femoral artery embolism in patients undergoing a laterally extended parametrectomy (LEP) procedure // Eur. J. Gynaecol. Oncol. 2011. Vol. 32. P. 401–402.

45. Undurraga M., Loubeyre P., Dubuisson J.B. et al. Early-stage cervical cancer: is surgery better than radiotherapy? // Expert Rev. Anticancer Ther. 2010. Vol. 10. P. 451–460.

46. Ungar L., Palfalvi L. Surgical treatment of lymph node metastases in stage IB cervical cancer: the laterally extended parametrectomy (LEP) procedure // Int. J. Gynecol. Cancer. 2003. Vol. 13. P. 647–651.

47. Van de Putte G., Lie A.K., Vach W. et al. Risk grouping in stage IB squamous cell cervical cancer // Gynecol. Oncol. 2005. Vol. 99. P. 106–112.

48. Wang S.S., Sherman M.E., Silverberg S.G. et al. Pathological characteristics of cervical adenocarcinoma in a multicenter US-based study // Gynecol. Oncol. 2006. Vol. 103. P. 541–546.

49. Wertheim E. The extended abdominal operation for carcinoma uteri (based on 500 operative cases) // Am. J. Obstet. Dis. Women Child. 1912. Vol. 66. P. 169–232.


Для цитирования:


Унгар Л., Нечушкина В.М. ПОЧЕМУ НУЖНО ВЫПОЛНЯТЬ РАСШИРЕНЫЕ ОПЕРАЦИ ПРИ РАКЕ ШЕЙКИ МАТКИ? Сибирский онкологический журнал. 2013;(3):5-13.

For citation:


Ungar L., Nechushkina V.M. WHY SHOULD WE PERFORM EXTENDED SURGERIES FOR CERVICAL CANCER? Siberian journal of oncology. 2013;(3):5-13. (In Russ.)

Просмотров: 196


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1814-4861 (Print)
ISSN 2312-3168 (Online)